October 2013
Intermediate to advanced
41 pages
49m
English
Content preview from BioCoder #1
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.
Biotech’s Cambrian Era
As I write this article, I’m reflecting on the long expanses of otherworldly playa I’ve just left, watching sandstorms pass in front of me while in altered mental states and contemplating the future of our beloved biotech industry.
I have, until recently been living a double life with one foot in the corporate biotech world and another deeply in the world of biohacking/radical science (working on DIY biolabs and equipment, longevity research, and ALS therapeutic development). I believe in the principles of citizen science and shared (or at least leaky) IP as a means of accelerating scientific progress, but I felt I needed to play my part in the “real” biotech industry. That changed three months ago when I realized that to create the innovation we want in biotech, we may have to burn the bridges that got us here and re-create it ourselves, with or without the dinosaur the current biotech industry has become.
Since 1978—arguably the birth of the biotech industry when Genentech created the first GMO producing insulin—Biotech has become profitable and also heavily regulated. Biotech venture capitalists, the original sources of risk capital, have become risk-fearing middlemen/women who have been cowed into seeking safe returns for their masters (limited partners) and obsessed with spinning the right story to their customers (big pharma/biotech companies). ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access
More than 5,000 organizations count on O’Reilly
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.Julian F.
I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.Addison B.
I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.Amir M.
I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.